What is the time to reach steady state for Aripiprazole (Abilify)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 18, 2025 • View editorial policy

From the Guidelines

Abilify (aripiprazole) typically takes about 2 weeks to reach steady state in the body. This is because the time to steady state is related to the drug's half-life, which for aripiprazole is approximately 75 hours (about 3 days) for most adults, as implied by its pharmacokinetic properties 1. The calculation of reaching steady state, which is generally considered to be about 5 half-lives, supports the notion that it takes roughly 2 weeks for the medication to stabilize in the bloodstream and exert its full therapeutic effects.

Key Points to Consider

  • The half-life of aripiprazole is a critical factor in determining how long it takes to reach steady state.
  • The medication's pharmacokinetics, including its metabolism and elimination, can influence the time to steady state, especially in patients with liver impairment or those taking interacting medications.
  • Consistent daily dosing is essential to achieve and maintain therapeutic levels of the medication.

Given the information provided in the guideline evidence 1, while it does not directly address the pharmacokinetics of aripiprazole in detail, understanding the principles of drug half-life and steady state is crucial for managing patient expectations and optimizing treatment outcomes. It is essential to continue taking Abilify exactly as prescribed, even if the full therapeutic benefits are not immediately apparent, to ensure that the medication reaches its steady state and exerts its intended effects.

From the FDA Drug Label

Steady-state concentrations are attained within 14 days of dosing for both active moieties. Dosage increases should generally not be made before 2 weeks, the time needed to achieve steady-state

Time to reach steady state:

  • 14 days for aripiprazole to reach steady-state concentrations 2
  • 2 weeks is the time needed to achieve steady-state, after which dosage increases can be made 3

From the Research

Pharmacokinetics of Aripiprazole

  • Aripiprazole is well absorbed, with peak plasma concentrations occurring within three to five hours after administration 4
  • The oral availability is 87% 4
  • The mean elimination half-life is about 75 hours for aripiprazole and 94 hours for its active metabolite 4

Steady State

  • To reach steady state, it typically takes 4-5 half-lives 4
  • Based on the half-life of aripiprazole (75 hours), it can be estimated that steady state is reached in approximately 15-20 days (4-5 half-lives) 4

Clinical Applications

  • Aripiprazole has been used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder 5, 6, 7
  • The medication has been shown to be effective in reducing symptoms of mania, depression, and anxiety 5, 6, 7

Related Questions

What is the best course of action for a 27-year-old patient with a past medical history (PMH) of schizophrenia, bipolar disorder, and psychosis, who was recently discharged from a state hospital and started on Abilify (aripiprazole) with good management of his psychiatric condition, and is now seeking a refill of the medication?
Does aripiprazole (Abilify) help with mood stability?
What is the interaction between Aripiprazole (Abilify) and Lorazepam (Ativan)?
What is Aripiprazole?
What is a suitable initial dose of Abilify (aripiprazole) for a 60-year-old patient?
What is the likely diagnosis in a 32-year-old man presenting with chronic non-bloody diarrhea, greasy stools, and weight loss, with increased bowel sounds on exam and a biopsy obtained from the second portion of the duodenum (Esophagogastroduodenoscopy (EGD))?
What are the causes of pediatric cyanosis (blue discoloration of the skin due to inadequate oxygenation)?
What is mastocytosis (Mast Cell Disorder)?
What is the cause of fatigue, brain fog, and depersonalization in a 73-year-old female after increasing her fluoxetine (Prozac) dosage?
What is the most likely diagnosis for a 49-year-old farmer presenting with chronic diarrhea, abdominal pain, arthralgia, steatorrhea, significant weight loss, and cognitive impairment, with endoscopic findings of pale, yellow, shaggy mucosa in the duodenum and jejunum, and biopsy revealing foamy macrophages in the lamina propria with Periodic Acid-Schiff (PAS)-positive intracellular material?
What is the diagnosis for a patient with elevated free Triiodothyronine (T3) levels, suppressed Thyroid-Stimulating Hormone (TSH) levels, and low Thyroxine (T4) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.